Cardiac disorders |
Tachycardia |
0 |
2 |
0 |
Gastrointestinal disorders |
Any AE - Maximum |
7 |
3 |
0 |
Abdominal pain |
2 |
2 |
0 |
Constipation |
1 |
1 |
0 |
Diarrhea |
1 |
0 |
0 |
Nausea |
7 |
0 |
0 |
Vomiting |
5 |
1 |
0 |
General disorders and administration site conditions |
Any AE - Maximum |
2 |
0 |
0 |
Fatigue |
2 |
0 |
0 |
Edema peripheral |
1 |
0 |
0 |
Pyrexia |
1 |
0 |
0 |
Investigations |
Any AE - Maximum |
3 |
0 |
1 |
Alanine aminotransferase increased |
1 |
0 |
0 |
Aspartate aminotransferase increased |
1 |
0 |
0 |
Blood creatinine increased |
3 |
0 |
0 |
Hemoglobin decreased |
0 |
0 |
1 |
Metabolism and nutrition disorders |
Any AE - Maximum |
4 |
2 |
0 |
Decreased appetite |
3 |
0 |
0 |
Hypercalcemia |
0 |
1 |
0 |
Hyperkalemia |
0 |
1 |
0 |
Hypocalcaemia |
2 |
0 |
0 |
Hypomagnesaemia |
0 |
1 |
0 |
Musculoskeletal and connective tissue disorders |
Any AE - Maximum |
1 |
1 |
0 |
Flank pain |
0 |
1 |
0 |
Myalgia |
1 |
0 |
0 |
Nervous system disorders |
Dizziness |
1 |
0 |
0 |
Renal and urinary disorders |
Hematuria |
1 |
0 |
0 |
Respiratory, thoracic and mediastinal disorders |
Dyspnea |
1 |
0 |
0 |
Vascular disorders |
Hypotension |
0 |
1 |
0 |
Injury, poisoning and procedural complications |
Radiation skin injury |
0 |
1 |
0 |
ANY AE - Maximum Grade Seen Total (percentage) |
|
6 (37.5) |
4 (25) |
1 (6) |